HBsAg loss in chronic hepatitis B: pointers to the benefits of curative therapy

Hepatol Int. 2016 Sep;10(5):727-9. doi: 10.1007/s12072-016-9738-1. Epub 2016 May 31.

Authors

Geoffrey Dusheiko^{1

2}, Bo Wang³, Ivana Carey³

Affiliations

¹ Kings College Hospital, London, UK. g.dusheiko@ucl.ac.uk.
² University College London Medical School, London, UK. g.dusheiko@ucl.ac.uk.
³ Kings College Hospital, London, UK.

PMID: 27246696
DOI: 10.1007/s12072-016-9738-1

No abstract available

Publication types

Editorial

MeSH terms

DNA, Viral / metabolism
Genotype
Hepatitis B Surface Antigens / immunology*
Hepatitis B Surface Antigens / metabolism
Hepatitis B virus / genetics
Hepatitis B virus / immunology*
Hepatitis B, Chronic / diagnosis
Hepatitis B, Chronic / immunology*
Hepatitis B, Chronic / virology*
Humans
Viral Load

Substances

DNA, Viral
Hepatitis B Surface Antigens